PFIZER INC Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31)
PFIZER INC (PFE) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31) of $381.00 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentOnDerivativesIncludedInNetIncomeBeforeTax · last filed 2013-05-10
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $381.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-12-31 was -$168.00M, a 152.50% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-09-30 was -$221.00M, a 133.84% decline year-over-year.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for the quarter ending 2012-07-01 was $427.00M.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for fiscal 2012 was -$263.00M, a 210.04% decline from fiscal 2011.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for fiscal 2011 was $239.00M, a 65.95% decline from fiscal 2010.
- PFIZER INC other comprehensive income (loss), reclassification adjustment on derivatives included in net income, before tax (deprecated 2013-01-31) for fiscal 2010 was $702.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, before Tax (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $381.00M 10-Q · filed 2013-05-10 | $213.00M derived: sum of 2 quarters · filed 2013-05-10 | -$8.00M derived: sum of 3 quarters · filed 2013-05-10 | $419.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-12-31 | -$168.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$389.00M derived: sum of 2 quarters · filed 2013-02-28 | $38.00M derived: sum of 3 quarters · filed 2013-02-28 | -$263.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | -$221.00M 10-Q · filed 2012-11-09 | $206.00M derived: sum of 2 quarters · filed 2012-11-09 | -$95.00M 10-Q · filed 2012-11-09 | $226.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-07-01 | $427.00M 10-Q · filed 2012-08-09 | $127.00M 10-Q · filed 2012-08-09 | $447.00M derived: sum of 3 quarters · filed 2013-05-10 | $1.10B derived: sum of 4 quarters · filed 2013-05-10 |
| 2012-04-01 | -$300.00M 10-Q · filed 2013-05-10 | $20.00M derived: sum of 2 quarters · filed 2013-05-10 | $673.00M derived: sum of 3 quarters · filed 2013-05-10 | $449.00M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $320.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $973.00M derived: sum of 2 quarters · filed 2013-02-28 | $749.00M derived: sum of 3 quarters · filed 2013-02-28 | $239.00M 10-K · filed 2013-02-28 |
| 2011-10-02 | $653.00M 10-Q · filed 2012-11-09 | $429.00M derived: sum of 2 quarters · filed 2012-11-09 | -$81.00M 10-Q · filed 2012-11-09 | |
| 2011-07-03 | -$224.00M 10-Q · filed 2012-08-09 | -$734.00M 10-Q · filed 2012-08-09 | ||
| 2010-12-31 | $702.00M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |